Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Notes underwriting agrmnt
|
|
Denali Capital Acquisition Corp.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
8-K
| Investor presentation |
| 01/26/2023 |
8-K/A
| Investor presentation|
Docs:
|
"COMPANY VOTING AND SUPPORT AGREEMENT This COMPANY VOTING AND SUPPORT AGREEMENT is entered into as of January 25, 2023, by and between Longevity Biomedical, Inc., a Delaware corporation , Denali Capital Acquisition Corp., a Cayman Islands exempted company with limited liability , Denali SPAC Holdco, Inc., a Delaware Corporation , and the securityholder of the Company set forth on Schedule I hereto . The Company, Purchaser and the Securityholder are sometimes referred to herein as a “ Party ” and collectively as the “ Parties ”. WITNESSETH : WHEREAS, as of the date hereof, the Securityholder is the holder of record and “ beneficially owns ” and is entitled to dispose of and to vote the number of shares of Company Common Stock set forth opposite its name on Schedule I hereto , are collectivel...",
"VOTING AND SUPPORT AGREEMENT This VOTING AND SUPPORT AGREEMENT is entered into as of January 25, 2023, by and between Longevity Biomedical, Inc., a Delaware corporation , Denali Capital Acquisition Corp., a Cayman Islands exempted company with limited liability , and Denali Capital Global Investment LLC, a Cayman Islands limited liability company . The Company and the Sponsor are sometimes referred to herein as a “ Party ” and collectively as the “ Parties ”. WITNESSETH : WHEREAS, as of the date hereof, the Sponsor “ beneficially owns ” and is entitled to dispose of and to vote the number of Class B ordinary shares, par value $0.0001 per share , of the Purchaser set forth opposite its name on Schedule I hereto , are collectively referred to herein as the “ Subject Shares ”); WHEREAS, the C...",
"INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORI TY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE POTENTIAL BUSINESS COMBINATION OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HE REI N. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. PROSPECTIVE INVESTORS MUST RELY SOLELY ON THEIR OWN EXAMINATION OF A POTENTIAL INVESTMENT IN THE COMPANY OR THE SPAC AND THE TER MS OF THE DEFINITIVE DOCUMENTATION, INCLUDING THE MERITS AND RISKS INVOLVED, AND NOT ON ANY INFORMATION OR REPRESENTATION MADE OR ALLEGED TO HAVE BEE N MADE HEREIN OR OTHERWISE." |
|
|
|